Skip to content

IFRX - InflaRx N.V. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchI

InflaRx N.V.

IFRX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

I

IFRXInflaRx N.V.

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $2.95
52-wk low: $0.80
Prev close: $1.86
Mkt cap: $312.4M
Beta: 2.52
P/S: 9842.6x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$30.3M

FC
Farallon Capital
Q2 2026 13F
$7.4M
position
MW
Marshall Wace
Q2 2026 13F

Earnings

Reported Aug 6, 2026

Earnings came in $0.03 a share below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $312M

Valuation

P/S9842.62
P/B1.90

Quality

Operating margin352965.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: IFRX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $312.42M
Beta: 2.52

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

1.9x

Profit margin

+0.0%

Op margin

+352965.0%

ROE

-38.5%

$1.6M

position

MI

Millennium

Israel Englander · Q2 2026 13F

$1.3M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for IFRX

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.11-$0.03

-$0.08 expected

Next report

What the street expects next

-38.5%

ROA-18.5%

Growth

Beta2.52